Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications

Conclusion: Our comprehensive investigation highlights SLC31A1 as a promising biomarker for bladder cancer development, progression, and therapy.PMID:38712735 | DOI:10.1177/03946320241240706

Source: International Journal of Immunopathology and Pharmacology - May 7, 2024 Category: Allergy & Immunology Authors: Yun-Zhi Lin Wei-Hui Liu Yu-Peng Wu Hai Cai Qing-Shui Zheng Yong Wei Ning Xu Xue-Yi Xue Source Type: research